Covid-19 roundup: Jun­shi, Eli Lil­ly ready to launch Covid-19 an­ti­body tri­al; Janet Wood­cock steps aside — for now — as FDA drug czar

Jun­shi Bio­sciences and their part­ners at Eli Lil­ly say they’re on track to launch the first hu­man tri­al of a new an­ti­body aimed at fight­ing Covid-19. The Chi­nese de­vel­op­er not­ed that re­searchers have found 2 an­ti­bod­ies in re­cov­er­ing pa­tients that demon­strate an abil­i­ty to spur the de­vel­op­ment of neu­tral­iz­ing an­ti­bod­ies in rhe­sus mon­keys, and they’re rush­ing straight in­to a hu­man study to put that pre­clin­i­cal work to the test.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER